Tag : medical cannabis

Current News Global

Australians Overwhelmingly Support Medical Cannabis

Editor
Ninety one percent of Australians support medicinal cannabis use. Chronic diseases like epilepsy, chronic pain, nausea in cancer related chemotherapy, multiple sclerosis, PTSD, and palliative care are already legally treated with medical marijuana. Because of the overwhelming support, experts claim that over-the-counter cannabis purchases are just a matter of time....
Politics

The Hawaiian Department of Health Implements New Amendments to Medical Cannabis Laws

Editor
Hawaiian Governor David Ige signed amendments into law that will improve access to medical cannabis for qualifying patients. The amendment is aimed at medical cannabis users with chronic health conditions. Instead of having to apply for permits each year, these documents will now be valid for three years. Patients still...
Politics

New York Department of Health to Allow Medical Cannabis as an Opioid Replacement

Editor
Earlier this month, the New York State Department of Health announced new emergency regulations to allow patients prescribed opioids to be given a license to obtain medicinal cannabis as an alternative. Opioids are synthetic based medicines that product effects similar to morphine. They are primarily used for pain management and...
Politics

Oklahoma Legalized Medical Marijuana with Vote This Week

Editor
The state of Oklahoma has become the 30th state in the U.S. to allow the use of medicinal marijuana for patients with a perception. Last Tuesday residents voted to pass Oklahoma State Question 788 which allows adults 18 and older to receive a license to possess, consume, and cultivate cannabis...
Current News Global

Emblem enters German Medical Cannabis Market with Acnos Joint Venture

Editor
Emblem Corp (TSXV: EMC) has announced a joint venture with German pharmaceutical wholesaler Acnos. The new entity formed by the partnership, Emblem Germany will allow Emblem branded cannabis products to be imported to Germany from Canada. Emblem is a Canadian producer and distributor of medical cannabis and cannabis derivatives located...
Current News Global

Portugal’s Parliament Legalizes Cannabis as a Prescribed Medicine for Patients

Editor
Last week, Portugal’s Parliament voted upon the right for its citizens to receive and gain prescriptions to cannabis-based medicines from their doctor.¬†The move is expected to help reduce patients dependence on pharmaceutical grade synthetic opioids in Portugal. More and more countries involved in the European Union have decided to join...
Politics

Illinois Governor to Decide to Allow Medicinal Cannabis as a Prescription Pain Killer Substitute

Editor
The state of Illinois and its lawmakers want to offer patients medicinal cannabis as an alternative to opioid derived perception pain killers. The new law would allow patients to purchase cannabis from licensed medical dispensaries, removing the required 4 month window for patients to receive a medical marijuana card. The...
CCT Impact Current News Featured Global

Developing the Cannabis Nursing Sector: Industry Insight with Elisabeth Mack, RN, MBA

Editor
The following is a guest post from Elizabeth Mack, RN, MBA: Medical Cannabis is an exit drug. An exit drug to sleep medications, antidepressants, and opioids. It is now known that the long-term use of opioids for chronic pain is associated with abuse and overdose, and we are currently experiencing...
Current News Growers Market Watch

Canopy Growth Corp. Doubles Production Capacity with New Licenses

Editor
Canopy Growth Crop. (TSX: WEED) has recently announced that it has received additional licensing that allows the company to increase its production capacity for its Tweed branded cannabis facilities in Canada. Canopy, and its majority owned subsidiary Tweed, owns one of the largest cannabis cultivation facilities in the world. The...
Cannabis News Global Market Watch

Aphria Continues International Expansion, Entering the Argentinian Cannabis Market

Editor
Aphria Inc. (TSX: APH) (OTC: APHQF) announced this morning that the company has signed an exclusive cannabis supply agreement with a non-disclosed Argentina based pharmaceutical import and distribution company. The non-disclosed company is currently licensed to import, sell and distribute medical products and derivatives to the people of Argentina. Under the...